Article Text

Download PDFPDF
152 Stem Cell Coated Metallic Coronary Stents Show Accelerated Strut Coverage without Excessive Neointimal Proliferation in a Porcine Model
  1. Tushar Raina1,
  2. Nadine Arnold1,
  3. Harry Moore1,
  4. Behrouz Aflatoonian1,
  5. Jim Walsh1,
  6. Sam Whitehouse1,
  7. Kadem Al-Lamee2,
  8. Sheila Francis1,
  9. Julian Gunn1,
  10. Javaid Iqbal1
  1. 1University of Sheffield
  2. 2Lombard Medical Technologies Plc


Introduction The success of percutaneous coronary intervention (PCI) has been limited by restenosis and stent thrombosis. Delayed or incomplete endothelial regeneration is believed to be a key factor responsible for these events. Developing a stent with an accelerated healing profile may be of benefit. We aimed to evaluate the feasibility and safety of seeding a bare metal stent (BMS) with human trophoblastic endovascular progenitor cells (hTEC) derived from human embryonic stem cells.

Methods hTEC were derived by the terminal differentiation of trophoblast stem cells while the latter were derived as distinct trophoblast cell lines from human embryonic stem cells. BMS were seeded with hTEC by co-culturing for 3 days. The biodistribution and fate of hTEC were studied using radiolabeled 111Indium oxine and fluorescent in-situ hybridisation. A porcine coronary artery model was used to compare the rate and extent of endothelial regeneration and the degree of neointimal proliferation.

Results Characterisation of hTEC confirmed a mixed progenitor and endothelial cell phenotype. For the stents seeded with 111Indium-labelled hTEC, the radioactivity measured over the explanted stented LAD was 77,642 cpm at 1 h, 20,048 cpm at 1 day and 2,323 cpm at 7 days, with no significant radioactivity detected at any of the distal sites including blood vessels, heart, lung, spleen, liver and kidneys. Scanning electron microscopy showed earlier endothelial coverage in hTEC-seeded stents as compared to similar BMS (Figure 1).

hTEC-seeded BMS achieved complete stent coverage in 3 days (Figure 2). Quantitative coronary angiography, intravascular ultrasound assessment and histomorphometry showed no difference in neointimal hyperplasia between hTEC-seeded and control BMS (Figure 2).

Conclusion hTEC seeding of coronary stents is a novel and safe approach to accelerate endothelial regeneration without increasing neointimal proliferation.

  • percutaneous coronary intervention
  • endothelialisation
  • endothelial progenitor cells

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.